KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Other Non Operating Income: 2013-2025

Historic Other Non Operating Income for CareDx (CDNA) over the last 12 years, with Sep 2025 value amounting to -$107,000.

  • CareDx's Other Non Operating Income fell 137.81% to -$107,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $696,000, marking a year-over-year decrease of 51.46%. This contributed to the annual value of $329,000 for FY2024, which is 75.50% down from last year.
  • CareDx's Other Non Operating Income amounted to -$107,000 in Q3 2025, which was down 248.61% from $72,000 recorded in Q2 2025.
  • In the past 5 years, CareDx's Other Non Operating Income ranged from a high of $2.8 million in Q2 2021 and a low of -$3.4 million during Q3 2021.
  • In the last 3 years, CareDx's Other Non Operating Income had a median value of $72,000 in 2025 and averaged $175,636.
  • Data for CareDx's Other Non Operating Income shows a peak YoY increase of 1,189.80% (in 2021) and a maximum YoY decrease of 1,254.33% (in 2021) over the last 5 years.
  • Over the past 5 years, CareDx's Other Non Operating Income (Quarterly) stood at -$1.7 million in 2021, then soared by 46.34% to -$924,000 in 2022, then surged by 266.77% to $1.5 million in 2023, then crashed by 71.71% to $436,000 in 2024, then crashed by 137.81% to -$107,000 in 2025.
  • Its Other Non Operating Income stands at -$107,000 for Q3 2025, versus $72,000 for Q2 2025 and $295,000 for Q1 2025.